Related Experiment Videos
Arterial protection: a neglected but crucial therapeutic goal
1University of Texas Southwestern Medical Center, Dallas 75235-8899.
Insights
Hypertension causes arterial damage through smooth muscle hypertrophy and atherosclerosis. Effective treatment requires managing blood pressure and associated risk factors for better outcomes.
Area of Science:
- Cardiovascular pathology
- Vascular biology
- Hypertension research
Background:
- Hypertension is linked to two main arterial conditions: arteriolar smooth muscle hypertrophy and atherosclerosis.
- Vascular hypertrophy can be a response to high blood pressure or a primary cause.
- Insulin and other growth factors may contribute to vascular hypertrophy.
Purpose of the Study:
- To explore the pathological mechanisms of hypertension-induced arterial damage.
- To evaluate the impact of antihypertensive treatments on vascular hypertrophy and atherosclerosis.
- To identify antihypertensive agents that offer better risk factor control and protection against atherosclerosis.
Main Methods:
- Review of existing literature on hypertension, vascular pathology, and antihypertensive therapies.
- Analysis of the roles of smooth muscle hypertrophy and atherosclerosis in hypertensive disease.
- Comparison of the effects of different classes of antihypertensive drugs on arterial health and metabolic risk factors.
Main Results:
- Hypertension accelerates atherosclerosis, particularly with co-existing risk factors like hypercholesterolemia, smoking, and diabetes.
- Antihypertensive treatment can reverse arterial damage if causative factors are addressed.
- Certain antihypertensive drugs (diuretics, non-ISA beta-blockers) can worsen lipid and glucose profiles, potentially reducing their benefits.
Conclusions:
- Reversal of vascular hypertrophy is possible by reducing blood pressure and trophic stimuli.
- Antihypertensive therapies that avoid adverse metabolic effects (e.g., alpha-blockers, ACE inhibitors, calcium channel blockers) may offer superior protection against atherosclerosis.
- A deeper understanding of hypertension's arterial effects will enable more targeted and effective clinical interventions.
Abstract:
Hypertension is accompanied by 2 major types of arterial pathologic conditions: smooth muscle hypertrophy of arteriolar resistance vessels and atherosclerosis, primarily involving the larger arteries. Smooth muscle hypertrophy may develop either as a secondary defense against elevated intravascular pressure or as a primary defect responsible for the increased pressure. Insulin and a number of other trophic stimuli may play a pathogenetic role in vascular hypertrophy. Reducing blood pressure and trophic stimuli may cause hypertrophy to be reversed. Because atherosclerosis may be markedly accelerated by hypertension, especially in the presence of concomitant risk factors, such as hypercholesterolemia, cigarette smoking and diabetes mellitus, antihypertensive treatment may attenuate or even reverse the extent of atherosclerosis, but only when the causative factors are also corrected. Some commonly used antihypertensive agents, e.g., diuretics and beta blockers without intrinsic sympathomimetic activity, often aggravate hypercholesterolemia and glucose intolerance, thereby diminishing their potential protective value. Other types of drug therapy, such as alpha blockers, beta blockers with intrinsic sympathomimetic activity or other vasodilator activity, angiotensin-converting enzyme inhibitors and calcium entry blockers that may not induce biochemical changes, should provide better control of multiple risks and thereby better protection against atherosclerosis. With a better understanding of how hypertension induces arterial damage, clinicians will be able to provide more appropriate treatment and, it is hoped, alleviate such damage.